Fax: (215) 349-8994
Are we ready to modify the Bethesda thyroid fine-needle aspiration classification scheme?†
Version of Record online: 6 NOV 2012
Copyright © 2012 American Cancer Society
Volume 121, Issue 4, pages 171–174, April 2013
How to Cite
Baloch, Z. W., Mandel, S. J. and LiVolsi, V. A. (2013), Are we ready to modify the Bethesda thyroid fine-needle aspiration classification scheme?. Cancer Cytopathology, 121: 171–174. doi: 10.1002/cncy.21234
See related article on pages 175–8, this issue.
- Issue online: 12 APR 2013
- Version of Record online: 6 NOV 2012
- Manuscript Revised: 21 AUG 2012
- Manuscript Accepted: 21 AUG 2012
- Manuscript Received: 17 AUG 2012
The diagnostic categories in the Bethesda thyroid fine-needle aspiration classification scheme represent the best that can be accomplished on the basis of cytomorphology alone, which effectively portrays its limitations. Therefore, it will require patience from diagnosticians who play an integral part in the management of thyroid nodules, because progress in medicine and in pathology needs to proceed in small steps to avoid confusion and mistreatment of patients.